The FDA Is Set To Approve Moderna’s Covid Vaccine—Yet The Three Billionaires Behind The Company Are Nearly $2 Billion Poorer

Despite being on the brink of major success, shares of the biotech outfit have fallen nearly 20% over the past 10 days.